Document is current
Any future updates will be listed below
-
Authors
Bailey, Cate https://orcid.org/0000-0001-5030-430X
Peasgood, Tessa https://orcid.org/0000-0001-8024-7801
-
Funding
Funding for this research was provided by:
EuroQol Research Foundation (1559)
University of Melbourne
- License Information
-
More Information
Article History
Accepted: 29 May 2025
First Online: 18 June 2025
Declarations
:
: Dr Peasgood is a member of the EuroQol group and was involved with the development of the EQ-HWB. Dr Peasgood is a member of the EQ-HWB working group and Dr Bailey is a member of the EQ-HWB special interest group. Dr Bailey is a member of the PharmacoEconomics editorial board. The authors have no competing interests to declare that are relevant to the content of this article.
: Funded by the EuroQol Foundation (1559-RA). Views expressed by the authors in the publication do not necessarily reflect the views of the EuroQol Foundation.
: Ethics approval was received from the University of Melbourne Human Ethics Committee (2023-27184-46174-5).
: Informed consent was obtained from all individual participants included in the study.
: It is not possible to share data because of the potential for individual privacy to be compromised.
: Both authors contributed to the study conception and design. Cate Bailey and Tessa Peasgood prepared the material and collected and analysed the data. Cate Bailey wrote the first draft of the manuscript, and both authors commented on subsequent versions. Both authors read and approved the final manuscript.
